Innovation

Big Pharma (2 of…)

Geez, I’m kind of overwhelmed by all the data for The Report. The life science sector is so big and complex. There’s no end to the information. I’ve had to say, “Enough!” to myself just to get started. Also the importance of the market-driven sector in cancer management keeps growing in my mind. I think this is key to anyone ...

Read More »

Who's the mother of invention?

Innovation is a theme of FI Center and of FISpace. It’s also a topic getting attention today nationally because, whatever their position on the “offshoring” issue, virtually everyone agrees that future prosperity in the US depends on being innovative, not on commodity ideas and labor. Also, the pharmaceutical industry about which I’m writing is having a crisis over innovation—or, rather, ...

Read More »

California-China Connection: China Syndromes (2 or 2)

Having gushed effusively about Leroy Hood, I’d like to turn to the China part of the conference. First, through, one last note about Hood. He had three messages for the Chinese: Everything he’s ever done that was important (including current work) has been met with great resistance. It’s not too late to get in on the ground floor of systems ...

Read More »

Social Software Planning

From a Voluntary Health Association perspective Social Software is an umbrella term for a series of business solutions that are focused on inter connecting and facilitating the organization of people. Much of what is being developed is not in it self-new. It is a new way of looking at and doing things. In fact many of the application are variants ...

Read More »